The use of bronchospheres to study chronic lung diseases

M. Konigshoff (Denver, United States of America)

Source: International Congress 2018 – Organoids and pluripotent stem cells
Session: Organoids and pluripotent stem cells
Session type: Symposium
Number: 276
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Konigshoff (Denver, United States of America). The use of bronchospheres to study chronic lung diseases. International Congress 2018 – Organoids and pluripotent stem cells

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tele-rehabilitation in chronic lung diseases
Source: ERS Course 2017
Year: 2017

Post-viral effects on the susceptibility of developing chronic lung diseases
Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease
Year: 2021


Senotherapies for chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020


The characteristics of mycobacterioses in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Role and distribution of infectious agents in exacerbations of moderate, severe and very severe forms of chronic obstructive lung disease: a prospective trial
Source: Eur Respir J 2006; 28: Suppl. 50, 735s
Year: 2006

The threat in chronic lung diseases: acute exacerbations
Source: Eur Respir Rev, 26 (145) 170075; 10.1183/16000617.0075-2017
Year: 2017



Prioritised research agenda for prevention and control of chronic respiratory diseases
Source: Eur Respir J 2010; 36: 995-1001
Year: 2010



Study of lung functions in patients of chronic liver disease.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017


Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007



Nintedanib in patients with chronic fibrosing interstitial lung diseases with progressive phenotype: the INBUILD trial
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension
Year: 2019




The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases
Source: Eur Respir Monogr 2017; 77: 224-246
Year: 2017


Inflammatory bowel diseases, chronic liver diseases and the lung
Source: Eur Respir J 2016; 47: 638-650
Year: 2016



Complex chronic comorbidities of COPD
Source: Eur Respir J 2008; 31: 204-212
Year: 2008



Recommendations for epidemiological studies on COPD
Source: Eur Respir J 2011; 38: 1261-1277
Year: 2011



Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002



Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006